The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Dose expansion data from iintune-1, a phase 1/2 study of the STING agonist dazostinag plus pembrolizumab as first-line (1L), in patients with recurrent/metastatic squamous cell carcinoma of the head and neck (RM-SCCHN).
 
Jérôme Fayette
Honoraria - Bristol-Myers Squibb; Merck Serono; Merck Sharp & Dohme; Sanofi
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Merck Serono; Merck Sharp & Dohme; Merus NV; Seagen; Takeda
Travel, Accommodations, Expenses - Merck Serono; Merck Sharp & Dohme
 
Aron Popovtzer
No Relationships to Disclose
 
Martin Forster
Consulting or Advisory Role - Achilles Therapeutics; Amgen; AstraZeneca; Bayer; Bristol-Myers Squibb/Celgene; Celgene; EQRx; GlaxoSmithKline UK Ltd.; Immutep; Janssen Oncology; Merck Serono; Merck Sharp & Dohme; Oxford VacMedix; Pfizer; PharmaMar; Regeneron; Roche; Takeda; Transgene; UltraHuman
Research Funding - Boehringer Ingelheim (Inst); Merck Serono (Inst); MSD Oncology (Inst)
Travel, Accommodations, Expenses - Achilles Therapeutics; AstraZeneca; Immutep; Janssen Oncology; MSD Oncology; Roche; Takeda
 
Douglas Adkins
Consulting or Advisory Role - Adlai Nortye; Boehringer Ingelheim; CUE Biopharma; Exelixis; Genmab/Seattle Genetics; Immunitas; InhibRx; Kura Oncology; Merck; Merck KGaA; Merus; NATCO Pharma; Purple Biotech; Regeneron; Sanofi; Seagen; TargImmune Therapeutics
Research Funding - Adlai Nortye (Inst); Alentis Therapeutics (Inst); AstraZeneca (Inst); AVEO (Inst); BeiGene (Inst); BioAtla (Inst); Blueprint Medicines (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Calliditas Therapeutics (Inst); Celgene (Inst); Cofactor Genomics (Inst); Coherus Biosciences (Inst); CUE Biopharma (Inst); Daiichi Sankyo Europe GmbH (Inst); Debiopharm Group (Inst); Epizyme (Inst); Erasca, Inc (Inst); Exelixis (Inst); Genmab (Inst); Gilead Sciences (Inst); GlaxoSmithKline (Inst); Hookipa Biotech (Inst); Immutep (Inst); InhibRx (Inst); ISA Pharmaceuticals (Inst); Johnson & Johnson/Janssen (Inst); Kura Oncology (Inst); Lilly (Inst); Merck (Inst); Merus (Inst); NATCO Pharma (Inst); Novartis (Inst); Pfizer (Inst); Rgenta (Inst); Roche (Inst); Seagen (Inst); Takeda (Inst); Tempus (Inst); Tizona Therapeutics, Inc. (Inst); Vaccinex (Inst); Xilio Therapeutics (Inst)
Travel, Accommodations, Expenses - NATCO Pharma (Inst)
 
Ye Guo
Honoraria - BeiGene; Merck Serono; MSD; Roche
Consulting or Advisory Role - AstraZeneca; GlaxoSmithKline; MSD
 
Gautier Lefebvre
No Relationships to Disclose
 
Jacob Thomas
Consulting or Advisory Role - Conjupro Biotherapeutics; Kura Oncology
 
Fiona Collinson
Speakers' Bureau - Bayer
Research Funding - Bristol-Myers Squibb; Roche/Genentech (Inst)
 
Ludovic Doucet
Travel, Accommodations, Expenses - MSD
 
Nathaniel Bouganim
Consulting or Advisory Role - AstraZeneca; Lilly; Merck; Novartis; Pfizer; Roche
 
Lei Liu
No Relationships to Disclose
 
Jaafar Bennouna
Honoraria - Amgen; AstraZeneca; Bristol-Myers Squibb; Daichii; Daichii; Ipsen; Janssen Oncology; MSD Oncology; Novartis; SERVIER
Consulting or Advisory Role - AMGEN; AstraZeneca; Bristol-Myers Squibb; MSD; Novartis; Roche; SERVIER
Research Funding - AstraZeneca (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; Roche
 
Richard Gregory
Employment - Takeda
Stock and Other Ownership Interests - Takeda
 
Cong Li
Employment - Takeda
Stock and Other Ownership Interests - Takeda
 
Radha Ramesh
Employment - Takeda
Stock and Other Ownership Interests - Takeda
 
Bingyan Wu
Employment - Takeda
 
Jeffrey Raizer
Employment - Takeda
Stock and Other Ownership Interests - Takeda
 
Yu-Chung Huang
Employment - Takeda
Stock and Other Ownership Interests - Takeda
 
Ammar Sukari
Stock and Other Ownership Interests - Bristol-Myers Squibb/Pfizer; Immunomedics
Honoraria - Merck KGaA
Speakers' Bureau - Coherus Biosciences; MSD